Related Experiment Video

Updated: Oct 5, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.0K

MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells

Charlène Estrada1,2,3,4,5, Liliana Mirabal-Ortega1,2,3,4,5,6, Laurence Méry1,2,3,4,5,6

  • 1Institut Curie, Centre de Recherche, F-91405, Orsay, France.

Communications Biology
|January 29, 2022
PubMed

Insights

Researchers discovered that RAF proteins directly bind to the MITF transcription factor in melanoma cells. This interaction traps MITF in the cytoplasm, reducing its activity and impacting melanoma progression and therapy resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The Microphthalmia-associated Transcription Factor (MITF) and the RAS/RAF/MEK/ERK pathway are critical in melanoma development.
  • MITF's dynamic regulation influences melanoma cell plasticity and therapeutic resistance.
  • Understanding MITF regulation is key to targeting melanoma progression.

Purpose of the Study:

  • To investigate the regulatory mechanisms of MITF in melanoma.
  • To identify novel interactions between MITF and the MAPK/ERK pathway components.
  • To elucidate the functional consequences of these interactions on melanoma cell behavior.

Main Methods:

  • Utilized mass spectrometry to identify protein interactions in NRAS-driven mouse melanoma.
  • Performed a functional siRNA screen to validate identified interactions.
  • Investigated protein complex formation and localization in mouse and human melanoma cells.

Main Results:

  • MITF was identified as a direct binding partner of ARAF, BRAF, and CRAF proteins.
  • These RAF/MITF interactions occur within the kinase domain of RAF proteins.
  • RAF/MITF complexes sequester MITF in the cytoplasm, inhibiting its transcriptional activity.

Conclusions:

  • A novel regulatory mechanism linking MITF and the MAPK/ERK pathway in melanoma was uncovered.
  • RAF proteins directly modulate MITF activity and localization.
  • This interaction represents a new layer of complexity in melanoma pathogenesis and offers potential therapeutic targets.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

321

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K